Nantahala Capital Management, LLC

Reported value$1.64Bas of Jun 30, 2026

Positions129 21 new, 22 sold out

Top 10 weight28%TBBK alone is 5%

FiledAug 1445 days after quarter end

Portfolio · as of Jun 30, 2026

Where the money is

New or addedTrimmedHeld

TBBK

BVS

HGV

Hilton Grand Vacations INC

3.3%Trimmed

SVRA

Savara INC

2.6%Trimmed

ETON

Eton Pharmaceuticals INC

2.6%

AMRX

Amneal Pharmaceuticals INC

2.4%Trimmed

EOLS

Evolus INC

2.4%Trimmed

AVTX

Avalo Therapeutics INC

2.1%Added

LBRX

Lb Pharmaceuticals INC

2.1%

AVR

Anteris Technologies Global

2.0%Trimmed

119 others

72.4%

Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.

What changed

Biggest moves since Mar 31, 2026

Filed Aug 14, 2026, compared with the May 15, 2026 filing

add_circleNew

ADMA $19.8M
VOR $15.6M
PLNT $14.6M
AMAN $12.2M

arrow_upwardAdded

ADCT +120%
QURE +92%
IRD +82%
FULC +80%

arrow_downwardTrimmed

TNGX −60%
ESTA −60%
PTON −57%
TLSI −52%

remove_circleSold out

Soleno Therapeutics INC $58.4M
Assertio Holdings INC $13.2M
Centessa Pharmaceuticals PLC $10.1M
COGT $9.62M